Regional and Whole-Body Dual-Energy X-Ray Absorptiometry to Guide Treatment and Monitor Disease Progression in Neuromuscular Disease - 11/01/12
Doi : 10.1016/j.pmr.2011.11.007
Andrew J. Skalsky, MD a, ⁎ 
, Jay J. Han, MD b, Richard T. Abresch, MS b, Craig M. McDonald, MD b
, Jay J. Han, MD b, Richard T. Abresch, MS b, Craig M. McDonald, MD b a Department of Pediatrics, University of California San Diego, Rady Children’s Hospital and Health Center, 3020 Children's Way, MC 5096, San Diego, CA 92123, USA
b Department of Physical Medicine and Rehabilitation, University of California Davis, 4860 Y Street, Suite 3850, Sacramento, CA 95817, USA
Corresponding author.Riassunto |
Dual-energy x-ray absorptiometry (DEXA) is a safe, noninvasive, inexpensive tool for managing patients with neuromuscular diseases. Regional and whole-body DEXA can be used to guide clinical treatments, such as determining body composition to guide nutritional recommendations, as well as to monitor disease progression by assessing regional and whole-body lean tissue mass. DEXA can also be used as an outcome measure for clinical trials.
Il testo completo di questo articolo è disponibile in PDF.Keywords : DEXA, Body composition, Lean mass, Fat mass
Mappa
© 2012
Elsevier Inc. Tutti i diritti riservati.
Vol 23 - N° 1
P. 67-73 - Febbraio 2012 Ritorno al numero
Articolo precedente
- Hypohomocysteinemia: A Potentially Treatable Cause of Peripheral Neuropathology?
- Clark E. Cullen, Gregory T. Carter, Michael D. Weiss, Peter A. Grant, David Scott Saperstein
- Establishing Clinical End Points of Respiratory Function in Large Animals for Clinical Translation
- Melissa A. Goddard, Erin L. Mitchell, Barbara K. Smith, Martin K. Childers
Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.
Già abbonato a @@106933@@ rivista ?